Author(s):
Nisha Kumari, Alok Kumar Upadhyay, Shweta Singh, Sachin Kumar
Email(s):
nishapandit742@gmail.com , alokupadhyay742@gmail.com , itmpharmacyhod@gmail.com , sachin05py37@gmail.com
DOI:
10.52711/2231-5713.2025.00046 
Address:
Nisha Kumari, Alok Kumar Upadhyay, Shweta Singh, Sachin Kumar
ITM, Gida, Gorakhpur, U.P.
*Corresponding Author
Published In:
Volume - 15,
Issue - 3,
Year - 2025
ABSTRACT:
Patches, which are more often known as transdermal drug delivery systems, are designed to introduce medication directly into the bloodstream via the skin. These systems offer multiple benefits, such as increased bioavailability by circumventing first-pass metabolism, decreased dose frequency, and higher patient adherence. This overview delineates the progression of topical drug delivery, from initial medicines to contemporary transdermal patches. Additionally, a coating, adhesive, membrane, drug reservoir, polymer matrix, and backing layer are often included in the composition of a transdermal patch. There are a variety of designs available, such as drug-in-adhesive, reservoir, matrix, and micro-reservoir systems. Additionally, there are revolutionary technologies available, such as microneedle patches and vapor-based patches. A significant step forward in this field is represented by the introduction of microneedle patches. Transdermal patches serve several purposes, such as pain relief, vaccination, gene therapy, insulin delivery, cardiovascular treatment, hormone replacement therapy, and the management of central nervous system problems. This review examines current breakthroughs, innovative applications, as well as the potential for the development of transdermal medication delivery methods.
Cite this article:
Nisha Kumari, Alok Kumar Upadhyay, Shweta Singh, Sachin Kumar. Recent Innovations and the Potential Applications of Transdermal Patches in Drug Delivery Research. Asian Journal of Pharmacy and Technology. 2025; 15(3):305-1. doi: 10.52711/2231-5713.2025.00046
Cite(Electronic):
Nisha Kumari, Alok Kumar Upadhyay, Shweta Singh, Sachin Kumar. Recent Innovations and the Potential Applications of Transdermal Patches in Drug Delivery Research. Asian Journal of Pharmacy and Technology. 2025; 15(3):305-1. doi: 10.52711/2231-5713.2025.00046 Available on: https://ajptonline.com/AbstractView.aspx?PID=2025-15-3-14
REFERENCES:
1. Shirsat K. M, Thakare M. M, Amale V. K, Kulkarni U. A, Shinde K. S. Formulation Development and Evaluation of Herbal Transdermal Patches from Leaf Extract of Thespesia Populnea Linn. for Anti- Inflammatory Activity. International Journal of Agriculture and Animal Production. 2024, 4(6), 25-44.
2. Rahman A, Ray B, Yadav S, Mishra S, Rai K. J, Jena j. A Review on Trasdermal Patch and Marketed Preparations, Journal of Xidian University. 2023, 17(10), 409-230.
3. Bhujbal D. S, Kanase S. A, Kunjir V. V. A Review on Herbal Transdermal Patches. International Journal of Advance Research and Innovative Ideas in Education. 2024, 10(2), 4261-4272.
4. Wong F. W, Ang P. k, Sethi G, Looi Y. C. Recent Advancement of Medical Patch for Transdermal Drug Delivery. Medicina. 2023, 59(778),1-20.
5. Shaikh N, Srivastava R. A review on transdermal drug delivery through patches. IP Indian Journal of Clinical and Experimental Dermatology. 2024, 10(2), 113-121.
6. Thakare D. P, Waghmare A. S, Pradyumna P. Advances In Transdermal Patch Formulation and Evaluation: A Comprehensive Review. International Journal of Pharmaceutical Sciences. 2024, 2(5), 1438-1452.
7. Ma Y, Gill H. S. Coating solid dispersions on microneedles via a molten dip-coating method: Development and in vitro evaluation for transdermal delivery of a water-insoluble drug. J. Pharm. Sci. 2014, 103, 3621–3630.
8. Chen B. Z, He M. C, Zhang X.P, Fei W. M, Cui Y, Guo X. D. A novel method for fabrication of coated microneedles with homogeneous and controllable drug dosage for transdermal drug delivery. Drug Deliv. Transl. Res. 2022, 12, 2730–2739.
9. Chen Y, Chen B. Z, Wang Q. L, Jin X, Guo X. D. Fabrication of coated polymer microneedles for transdermal drug delivery. J. Control. Release. 2017, 265, 14–21.
10. Gill H. S, Prausnitz M. R. Coated microneedles for transdermal delivery. J. Control. Release. 2007, 117, 227–237.
11. Cheung K, Das D.B. Microneedles for drug delivery Trends and progress. Drug Deliv. 2016, 23, 2338–2354.
12. Ita K. Transdermal Delivery of Drugs with Microneedles-Potential and Challenges. Pharmaceutics. 2015, 7, 90–105.
13. Ashraf M. W, Tayyaba S, Nisar A, Afzulpurkar N, Bodhale D. W, Lomas T, et al. Design fabrication and analysis of silicon hollow microneedles for transdermal drug delivery system for treatment of hemodynamic dysfunctions. Cardiovasc. Eng. 2010, 10, 91–108.
14. Mahony C, Sebastian R, Tjulkins F, Whelan D, Bocchino A, Hu Y, et al. Hollowsilicon microneedles fabricated using combined wet and dry etching techniques for transdermal delivery and diagnostics. Int. J. Pharm. 2023, 637, 122888.
15. Kim Y. C, Park J. H, Prausnitz M. R. Microneedles for drug and vaccine delivery. Adv. Drug Deliv. Rev. 2012, 64, 1547–1568.
16. Li W. Z, Huo M. R, Zhou J. P, Zhou Y. Q, Hao B. H, Liu T, et al. Super-short solid silicon microneedles for transdermal drug delivery applications. Int. J. Pharm. 2010, 389, 122–129.
17. Permana A. D, Tekko I. A, McCrudden M. T. C, Anjani Q. K, Ramadon D, McCarthy H. O, et al. Solid lipid nanoparticle-based dissolving microneedle A promising intradermal lymph targeting drug delivery system with potential for enhanced treatment of lymphatic filariasis. J. Control. Release. 2019, 316, 34–52.
18. Dalvi M, Kharat P, Thakor P, Bhavana V, Singh S.B, Mehra N. K. Panorama of dissolving microneedles for transdermal drug delivery. Life Sci. 2021, 284, 119877.
19. Dillon C, Hughes H, O’Reilly N. J, McLoughlin P. Formulation and characterisation of dissolving microneedles for the transdermal delivery of therapeutic peptides, Int. J. Pharm., 2017, 526, 125–136.
20. Ita K. Dissolving microneedles for transdermal drug delivery. Advances and challenges. Biomed. Pharmacother. 2017, 93, 1116–1127.
21. Lee J. W, Park J. H, Prausnitz M. R. Dissolving microneedles for transdermal drug delivery. Biomaterials. 2008, 29, 2113–2124.
22. Veiseh O, Langer R. Diabetes: A smart insulin patch. Nature. 2015, 524, 39–40.
23. Yu J, Zhang Y, Ye Y, DiSanto R, Sun W, Ranson D, et al. Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery. Proc. Natl. Acad. Sci. USA 2015, 112, 8260–8265.
24. Rodgers A. M, McCrudden M. T, Courtenay A. J, Kearney M. C, Edwards K.L, Ingram R. J., et al. Control of Klebsiella pneumoniae Infection in Mice by Using Dissolving Microarray Patches Containing Gentamicin. Antimicrob. Agents Chemother. 2019, 63, e02612-18.
25. Economidou S. N, Pissinato Pere C, Okereke M., Douroumis D. Optimisation of Design and Manufacturing Parameters of 3D Printed Solid Microneedles for Improved Strength, Sharpness and Drug Delivery. Micromachines. 2021, 12, 117.
26. Jang M. J, Bae S. K, Jung Y. S, Kim J. C, Kim J. S, Park S. K. et al. Enhanced wound healing using a 3D printed VEGF-mimicking peptide incorporated hydrogel patch in a pig model. Biomed. Mater. 2021, 16, 045013.
27. Zhang S, Liu C, Song Y, Ruan J, Quan, Fang L. High drug-loading and controlled-release hydroxyphenyl-polyacrylate adhesive for transdermal patch. J. Control. Release. 2023, 353, 475–489.
28. Yang D, Liu C, Piao H, Quan P, Fang L. Enhanced Drug Loading in the Drug-in-Adhesive Transdermal Patch Utilizing a Drug-Ionic Liquid Strategy. Insight into the Role of Ionic Hydrogen Bonding. Mol. Pharm. 2021, 18, 1157–1166.
29. Yang D, Liu C, Quan P, Fang L. Molecular mechanism of high capacity-high release transdermal drug delivery patch with carboxyl acrylate polymer: Roles of ion-ion repulsion and hydrogen bond. Int. J. Pharm. 2020, 585, 119376.
30. Bajaj S, Whiteman A, Brandner B. Transdermal drug delivery in pain management. Continuing Education in Anaesthesia Critical Care & Pain. 2011, 11(2), 39-43.
31. Jumbelic M. I. Deaths with transdermal fentanyl patches. Am J Forensic Med Pathol. 2010, 31, 18–21.
32. Griessinger H, Sittl R, Likar R. Transdermal buprenorphine in clinical practice—a post-marketing surveillance study in 13179 patients. Curr Med Res Opin. 2005, 21, 1147–56.
33. Choi, I.J. Cha, H.R, Hwang, S.J, Baek, S.K, Lee, J.M. Live Vaccinia Virus-Coated Microneedle Array Patches for Smallpox Vaccination and Stockpiling. Pharmaceutics 2021, 13, 209.
34. Sullivan S. P, Koutsonanos D. G, Del Pilar Martin M, Lee J. W, Zarnitsyn V, Choi S. O. et al. Dissolving polymer microneedle patches for influenza vaccination. Nat. Med. 2010, 16, 915–920.
35. Xu Q, Li X, Zhang P, Wang Y. Rapidly dissolving microneedle patch for synergistic gene and photothermal therapy of subcutaneous tumor. J. Mater. Chem. B. 2020, 8, 4331–4339.
36. Islam M. R, Uddin S, Chowdhury M. R, Wakabayashi R, Moniruzzaman M, Goto M. Insulin Transdermal Delivery System for Diabetes Treatment Using a Biocompatible Ionic Liquid-Based Microemulsion. ACS Appl. Mater. Interfaces. 2021, 13, 42461–42472.
37. Ogawa R, Stachnik J. M, Echizen H. Clinical pharmacokinetics of drugs in patients with heart failure: An update (part 1, drugs administered intravenously). Clin. Pharmacokinet. 2013, 52, 169–185.
38. Balfour J. A, Heel R. C. Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints. Drugs. 1990, 40, 561–582.
39. Priano L, Gasco M. R, Mauro A. Transdermal treatment options for neurological disorders: Impact on the elderly. Drugs Aging. 2006, 23, 357–375.